title: Herpes simplex virus type 2 in the United States, 1976 to 1994.
abstract: BACKGROUND
  Herpes simplex virus type 2 (HSV-2) infection is usually transmitted sexually and can cause recurrent, painful genital ulcers. In neonates the infection is potentially lethal. We investigated the seroprevalence and correlates of HSV-2 infection in the United States and identified changes in HSV-2 seroprevalence since the late 1970s.
  
  
  METHODS
  Serum samples and questionnaire data were collected during the National Health and Nutrition Examination Surveys (NHANES) II (1976 to 1980) and III (1988 to 1994). HSV-2 antibody was assessed with an immunodot assay specific for glycoprotein gG-2 of HSV-2.
  
  
  RESULTS
  From 1988 to 1994, the seroprevalence of HSV-2 in persons 12 years of age or older in the United States was 21.9 percent (95 percent confidence interval, 20.2 to 23.6 percent), corresponding to 45 million infected people in the noninstitutionalized civilian population. The seroprevalence was higher among women (25.6 percent) than men (17.8 percent) and higher among blacks (45.9 percent) than whites (17.6 percent). Less than 10 percent of all those who were seropositive reported a history of genital herpes infection. In a multivariate model, the independent predictors of HSV-2 seropositivity were female sex, black race or Mexican-American ethnic background, older age, less education, poverty, cocaine use, and a greater lifetime number of sexual partners. As compared with the period from 1976 to 1980, the age-adjusted seroprevalence of HSV-2 rose 30 percent (95 percent confidence interval, 15.8 to 45.8 percent). The seroprevalence quintupled among white teenagers and doubled among whites in their twenties. Among blacks and older whites, the increases were smaller.
  
  
  CONCLUSIONS
  Since the late 1970s, the prevalence of HSV-2 infection has increased by 30 percent, and HSV-2 is now detectable in roughly one of five persons 12 years of age or older nationwide. Improvements in the prevention of HSV-2 infection are needed, particularly since genital ulcers may facilitate the transmission of the human immunodeficiency virus.
authors.affiliation: National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
authors.forename: D T
authors.initials: DT
authors.lastname: Fleming
authors.forename: G M
authors.initials: GM
authors.lastname: McQuillan
authors.forename: R E
authors.initials: RE
authors.lastname: Johnson
authors.forename: A J
authors.initials: AJ
authors.lastname: Nahmias
authors.forename: S O
authors.initials: SO
authors.lastname: Aral
authors.forename: F K
authors.initials: FK
authors.lastname: Lee
authors.forename: M E
authors.initials: ME
authors.lastname: St Louis
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000914:Antibodies, Viral / Q000097:blood*; D044383:Black People; D002648:Child; D005260:Female; D006306:Health Surveys; D006558:Herpes Genitalis / Q000453:epidemiology* / Q000208:ethnology; D018258:Herpesvirus 2, Human / Q000276:immunology*; D006801:Humans; D016015:Logistic Models; D008297:Male; D017058:Mexican Americans; D008875:Middle Aged; D015999:Multivariate Analysis; D015995:Prevalence; D016036:Seroepidemiologic Studies; D017678:Sex Distribution; D014481:United States / Q000453:epidemiology; D044465:White People; D001741:Black or African American
chemical_list: D000914:Antibodies, Viral